Mapping esophageal cancer genes leads to new drug targets
Monday, February 4, 2019 - 16:00
in Health & Medicine
Mutations that cause esophageal adenocarcinoma (OAC) have been mapped in unprecedented detail -- unveiling that more than half could be targeted by drugs currently in trials for other cancer types.